The role of placental carbonyl reducing enzymes in biotransformation of bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone

Valentina Fokina, Svetlana L. Patrikeeva, Cheryl Oncken, Gary Hankins, Mahmoud Ahmed, Tatiana Nanovskaya

Research output: Contribution to journalArticle

Abstract

Background: Bupropion (BUP) has a potential to be an effective pharmacotherapy for smoking cessation during pregnancy. Smoking during pregnancy stimulates placental carbonyl reductases that catalyze the biotransformation of BUP. 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen of cigarette smoke. Carbonyl reduction of NNK into 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) constitutes a major step in NNK detoxification. Thus, placentas of pregnant smokers on BUP therapy can become a site of drug-drug interaction. Therefore, we investigated the effect of continuous exposure to BUP and cigarette smoke on the activity of placental carbonyl reductases in the formation of NNAL from NNK. Methods: The reductive metabolism of NNK was determined using microsomal and cytosolic subcellular fractions of placentas obtained from non-smoking women treated with BUP for depression, and women not exposed to BUP: non-smokers (control) and smokers. The effect of BUP and its metabolites on the reductive metabolism of NNK was investigated using subcellular fractions of control placentas. Results: The formation of NNAL from NNK by placental cytosolic fractions of heavy smokers (≥20 cigarettes per day) was lower than that of control (12.1±3.5 nmol.mgP-1 vs 16.5±6.0 nmol.mgP-1, P<0.05). While being exposed to BUP, the activity of placental carbonyl reductases remained unaffected, the formation of NNAL in the placental cytosolic fraction decreased only in the presence of high concentrations of BUP metabolites. Conclusion: Smoking during pregnancy decreases the detoxifying capacity of soluble carbonyl reductases towards NNK. Given the experimental conditions, exposure to BUP and its metabolites should not impede the reductive metabolism of NNK by placenta in vivo.

Original languageEnglish (US)
Pages (from-to)29-34
Number of pages6
JournalDrug Metabolism Letters
Volume11
Issue number1
DOIs
StatePublished - Mar 1 2017

Fingerprint

Bupropion
Biotransformation
Alcohol Oxidoreductases
Enzymes
Placenta
Metabolites
Metabolism
Tobacco Products
Subcellular Fractions
Smoke
Pregnancy
Smoking
4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
Drug interactions
Drug therapy
Detoxification
Smoking Cessation
Drug Interactions
Carcinogens
Depression

Keywords

  • Bupropion
  • Carbonyl reductases
  • NNAL
  • NNK
  • Placenta
  • Smoking

ASJC Scopus subject areas

  • Pharmaceutical Science
  • Clinical Biochemistry
  • Biochemistry, medical
  • Pharmacology (medical)

Cite this

The role of placental carbonyl reducing enzymes in biotransformation of bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone. / Fokina, Valentina; Patrikeeva, Svetlana L.; Oncken, Cheryl; Hankins, Gary; Ahmed, Mahmoud; Nanovskaya, Tatiana.

In: Drug Metabolism Letters, Vol. 11, No. 1, 01.03.2017, p. 29-34.

Research output: Contribution to journalArticle

@article{41f2b09a9f9e4fe0a3c69e05bb16def8,
title = "The role of placental carbonyl reducing enzymes in biotransformation of bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone",
abstract = "Background: Bupropion (BUP) has a potential to be an effective pharmacotherapy for smoking cessation during pregnancy. Smoking during pregnancy stimulates placental carbonyl reductases that catalyze the biotransformation of BUP. 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen of cigarette smoke. Carbonyl reduction of NNK into 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) constitutes a major step in NNK detoxification. Thus, placentas of pregnant smokers on BUP therapy can become a site of drug-drug interaction. Therefore, we investigated the effect of continuous exposure to BUP and cigarette smoke on the activity of placental carbonyl reductases in the formation of NNAL from NNK. Methods: The reductive metabolism of NNK was determined using microsomal and cytosolic subcellular fractions of placentas obtained from non-smoking women treated with BUP for depression, and women not exposed to BUP: non-smokers (control) and smokers. The effect of BUP and its metabolites on the reductive metabolism of NNK was investigated using subcellular fractions of control placentas. Results: The formation of NNAL from NNK by placental cytosolic fractions of heavy smokers (≥20 cigarettes per day) was lower than that of control (12.1±3.5 nmol.mgP-1 vs 16.5±6.0 nmol.mgP-1, P<0.05). While being exposed to BUP, the activity of placental carbonyl reductases remained unaffected, the formation of NNAL in the placental cytosolic fraction decreased only in the presence of high concentrations of BUP metabolites. Conclusion: Smoking during pregnancy decreases the detoxifying capacity of soluble carbonyl reductases towards NNK. Given the experimental conditions, exposure to BUP and its metabolites should not impede the reductive metabolism of NNK by placenta in vivo.",
keywords = "Bupropion, Carbonyl reductases, NNAL, NNK, Placenta, Smoking",
author = "Valentina Fokina and Patrikeeva, {Svetlana L.} and Cheryl Oncken and Gary Hankins and Mahmoud Ahmed and Tatiana Nanovskaya",
year = "2017",
month = "3",
day = "1",
doi = "10.2174/1872312811666170607095202",
language = "English (US)",
volume = "11",
pages = "29--34",
journal = "Drug Metabolism Letters",
issn = "1872-3128",
publisher = "Bentham Science Publishers B.V.",
number = "1",

}

TY - JOUR

T1 - The role of placental carbonyl reducing enzymes in biotransformation of bupropion and 4-methylnitrosamino-1-(3-pyridyl)-1-butanone

AU - Fokina, Valentina

AU - Patrikeeva, Svetlana L.

AU - Oncken, Cheryl

AU - Hankins, Gary

AU - Ahmed, Mahmoud

AU - Nanovskaya, Tatiana

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Background: Bupropion (BUP) has a potential to be an effective pharmacotherapy for smoking cessation during pregnancy. Smoking during pregnancy stimulates placental carbonyl reductases that catalyze the biotransformation of BUP. 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen of cigarette smoke. Carbonyl reduction of NNK into 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) constitutes a major step in NNK detoxification. Thus, placentas of pregnant smokers on BUP therapy can become a site of drug-drug interaction. Therefore, we investigated the effect of continuous exposure to BUP and cigarette smoke on the activity of placental carbonyl reductases in the formation of NNAL from NNK. Methods: The reductive metabolism of NNK was determined using microsomal and cytosolic subcellular fractions of placentas obtained from non-smoking women treated with BUP for depression, and women not exposed to BUP: non-smokers (control) and smokers. The effect of BUP and its metabolites on the reductive metabolism of NNK was investigated using subcellular fractions of control placentas. Results: The formation of NNAL from NNK by placental cytosolic fractions of heavy smokers (≥20 cigarettes per day) was lower than that of control (12.1±3.5 nmol.mgP-1 vs 16.5±6.0 nmol.mgP-1, P<0.05). While being exposed to BUP, the activity of placental carbonyl reductases remained unaffected, the formation of NNAL in the placental cytosolic fraction decreased only in the presence of high concentrations of BUP metabolites. Conclusion: Smoking during pregnancy decreases the detoxifying capacity of soluble carbonyl reductases towards NNK. Given the experimental conditions, exposure to BUP and its metabolites should not impede the reductive metabolism of NNK by placenta in vivo.

AB - Background: Bupropion (BUP) has a potential to be an effective pharmacotherapy for smoking cessation during pregnancy. Smoking during pregnancy stimulates placental carbonyl reductases that catalyze the biotransformation of BUP. 4-methylnitrosamino-1-(3-pyridyl)-1-butanone (NNK) is a potent carcinogen of cigarette smoke. Carbonyl reduction of NNK into 4-methylnitrosamino-1-(3-pyridyl)-1-butanol (NNAL) constitutes a major step in NNK detoxification. Thus, placentas of pregnant smokers on BUP therapy can become a site of drug-drug interaction. Therefore, we investigated the effect of continuous exposure to BUP and cigarette smoke on the activity of placental carbonyl reductases in the formation of NNAL from NNK. Methods: The reductive metabolism of NNK was determined using microsomal and cytosolic subcellular fractions of placentas obtained from non-smoking women treated with BUP for depression, and women not exposed to BUP: non-smokers (control) and smokers. The effect of BUP and its metabolites on the reductive metabolism of NNK was investigated using subcellular fractions of control placentas. Results: The formation of NNAL from NNK by placental cytosolic fractions of heavy smokers (≥20 cigarettes per day) was lower than that of control (12.1±3.5 nmol.mgP-1 vs 16.5±6.0 nmol.mgP-1, P<0.05). While being exposed to BUP, the activity of placental carbonyl reductases remained unaffected, the formation of NNAL in the placental cytosolic fraction decreased only in the presence of high concentrations of BUP metabolites. Conclusion: Smoking during pregnancy decreases the detoxifying capacity of soluble carbonyl reductases towards NNK. Given the experimental conditions, exposure to BUP and its metabolites should not impede the reductive metabolism of NNK by placenta in vivo.

KW - Bupropion

KW - Carbonyl reductases

KW - NNAL

KW - NNK

KW - Placenta

KW - Smoking

UR - http://www.scopus.com/inward/record.url?scp=85038810120&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038810120&partnerID=8YFLogxK

U2 - 10.2174/1872312811666170607095202

DO - 10.2174/1872312811666170607095202

M3 - Article

C2 - 28595558

AN - SCOPUS:85038810120

VL - 11

SP - 29

EP - 34

JO - Drug Metabolism Letters

JF - Drug Metabolism Letters

SN - 1872-3128

IS - 1

ER -